Bosentan Effects on Hemodynamics and Clinical Outcome in Hea…

Established


30
Citations
20
Refs
2011
Year
Search Works
Work Details
  • DOI 10.1055/s-0030-1250726
  • PMID https://pubmed.ncbi.nlm.nih.gov/21432755
  • OpenAlex ID W2164445114
  • Type Article
  • Language EN
  • Published 22 Mar 2011
  • Volume 60 (01)
  • Pages 026–034
  • Source The Thoracic and Cardiovascular Surgeon
  • Publisher Georg Thieme Verlag
  • FWCI 3.81
  • Countries 1
  • Institutions 1
  • Added 24 Jun 2016
  • Updated 31 Oct 2026
MENU
0

Bosentan Effects on Hemodynamics and Clinical Outcome in Heart Failure Patients with Pulmonary Hypertension Awaiting Cardiac Transplantation

Article 2011 EN Bronze

BACKGROUND: In heart failure (HF) patients, pulmonary hypertension (PH) is associated with a poor prognosis. We assessed whether low dose treatment with the dual endothelin-1 receptor antagonist bosentan is associated with improved hemodynamics and clinical outcome in these patients. METHODS: We performed a retrospective data analysis in 82 end-stage heart failure patients on the waiting list for…

30

Citations

20

References

6

Authors

3.81

FWCI

Citations by Year
Last 11 years
Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
6 authors
#AuthorInstitutionsORCID
1 T.K. Hefke Heart and Diabetes Center Nort… (DE) —
2 Armin Zittermann Heart and Diabetes Center Nort… (DE)
3 Uwe Fuchs Heart and Diabetes Center Nort… (DE) —
4 S. Schulte-Eistrup Heart and Diabetes Center Nort… (DE) —
5 Jan Fritz Gummert Heart and Diabetes Center Nort… (DE)
6 Uwe Schulz Heart and Diabetes Center Nort… (DE)

Data: OpenAlex